Effect of Telemedicine Support for Intraoperative Anaesthesia Care on Postoperative Outcomes: The TECTONICS Randomized Clinical Trial

Christopher R King,Bradley A. Fritz,Stephen H Gregory,Thaddeus P Budelier,Arbi Ben Abdallah,Alex Kronzer,Daniel L Helsten,Brian Torres,Sherry L McKinnon,Sandhya Tripathi,Mohamed Abdelhack,Shreya Goswami,Arianna Montes de Oca,Divya Mehta,Miguel A. Valdez,Evangelos Karanikolas,Omokhaye Higo,Paul Kerby,Bernadette Henrichs,Troy S Wildes,Mary C Politi,Joanna Abraham,Michael S Avidan,Thomas Kannampallil
DOI: https://doi.org/10.1101/2024.05.21.24307593
2024-05-23
Abstract:Background: Novel applications of telemedicine can improve care quality and patient outcomes. Telemedicine for intraoperative decision support has not been rigorously studied. Methods: This single centre randomised clinical trial (clinicaltrials.gov ) of unselected adult surgical patients was conducted between July 1, 2019 and January 31, 2023. Patients received usual care or decision support from a telemedicine service, the Anesthesiology Control Tower (ACT). The ACT provided real-time recommendations to intraoperative anaesthesia clinicians based on case reviews, machine-learning forecasting, and physiologic alerts. ORs were randomised 1:1. Co-primary outcomes of 30-day all-cause mortality, respiratory failure, acute kidney injury (AKI), and delirium were analysed as intention-to-treat. Results: The trial completed planned enrolment with 71927 surgeries (35956 ACT; 35971 usual care). After multiple testing correction, there was no significant effect of the ACT vs. usual care on 30-day mortality [641/35956 (1.8%) vs 638/35971 (1.8%), risk difference 0.0% (95% CI -0.2% to 0.3%), p=0.96], respiratory failure [1089/34613 (3.1%) vs 1112/34619 (3.2%), risk difference -0.1% (95% CI -0.4% to 0.3%), p=0.96], AKI [2357/33897 (7%) vs 2391/33795 (7.1%), risk difference -0.1% (-0.6% to 0.4%), p=0.96], or delirium [1283/3928 (32.7%) vs 1279/3989 (32.1%), risk difference 0.6% (-2.0% to 3.2%), p=0.96]. There were no significant differences in secondary outcomes or in sensitivity analyses. Conclusions: In this large RCT of a novel application of telemedicine-based remote monitoring and decision support using real-time alerts and case reviews, we found no significant differences in postoperative outcomes. Large-scale intraoperative telemedicine is feasible, and we suggest future avenues where it may be impactful.
What problem does this paper attempt to address?
This paper explores the role of remote medical support in perioperative anesthesia care, specifically whether a remote monitoring and decision support system called the Anesthesia Control Tower (ACT) improves postoperative patient outcomes. The study design was a single-center randomized clinical trial (TECTONICS), comparing 71927 surgical patients between July 2019 and January 2023, with half of the patients receiving real-time recommendations from ACT and the other half receiving standard care. The primary outcomes included all-cause mortality within 30 days, respiratory failure, acute kidney injury, and postoperative delirium. The results showed no significant differences between the ACT group and the standard care group in all primary and secondary outcomes. Despite the ability of ACT to provide real-time alerts, machine learning predictions, and physiological condition reminders, no significant reduction in postoperative complications was observed with these interventions. Therefore, the study concluded that large-scale intraoperative remote medical monitoring and decision support did not demonstrate significant benefits in improving postoperative patient outcomes but indicated potential areas of impact for future applications of this technology.